ClinicalTrials.gg
RecruitingNCT07008261Updated Sep 2, 2025

Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.

An observational study in Transfusions, Cystectomy and Blood Loss Requiring Transfusion, sponsored by Goethe University. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-02.

Sponsored by Goethe University · Observational

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 151 studies in Anemia with a site in Germany — 14 open to participants now, 27 under way, 14 of them phase 3. Anemia · Germany.

Planned enrollment
26th of 31
60 · median 800
Started
2025
with 2 others
Observational
31 of 151
8 open now
Primary completion
2027-05
later than 13 of 26 live
Registered
147th of 151
by date

Among the 151 studies in Anemia with a site in Germany, this one is the 26th largest by planned enrollment of the 31 observational ones that give a count, is one of 3 that started in 2025, is one of 31 observational ones, reaches primary completion later than 13 of the 26 other live ones, and was the 147th registered.

Anemia

1,812 studies on the registry are indexed under Anemia; 212 are open to participants now.

Browse Anemia studies →

Open to participants now

14 of the 151 studies in Anemia with a site in Germany are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 117 Anemia studies recruiting now, 66 (56%) set no upper age limit and 33 (28%) stop at 75 or younger; 32 take children under 18; 21 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 151 studies in Anemia with a site in Germany, or all of them as a file.
02

Study summary

What influence does robot-assisted surgical treatment in the sense of a radical cystectomy and possibly bladder reconstruction have on blood loss, pain and transfusion requirements? We intend to conduct a corresponding prospective observational study at a tertiary centre.

03

Conditions studied

  • Transfusions
  • Cystectomy
  • Blood Loss Requiring Transfusion
  • Anaemia
  • Anaemia Postoperative
  • Pain, Postoperative
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with a mostly oncological indication for radical cystectomy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • planned radical cystectomy

Exclusion criteria

Exclusion Criteria:

  • V
  • Previously known coagulation disorder
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Robot assistet

    Robot assistet laparoscopic cystectomy

  • Conventional

    Conventional laparotomy for cystektomie

06

What researchers measure

Primary outcomes

  1. perioperative blood loss

    perioperative blood loss

    Time frame: 6 hours

Secondary outcomes

  1. Preoperative iron deficiency

    Preoperative messured iron deficiency

    Time frame: up to 4 weeks prior surgery

  2. RBC transfusion

    Number of RBC transfusions

    Time frame: perioperative up to hospital discharge or death (up to 4 weeks)

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for May 2027, 21 months after the start.

Of 124 non-industry observational studies under Anemia, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 83. This study's planned 21 months is below that.

Counting every sponsor, half of 145 studies reached it within 30 months; a quarter within 11 and three quarters within 72.

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2025
First posted
Jun 6, 2025
StartActual
Aug 1, 2025
Primary completionEst.
May 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Sep 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07008261
Lead sponsor
Goethe University
Responsible party
Armin N. Flinspach (senior physician, Goethe University) — Principal investigator
First posted
Jun 6, 2025
Start date
Aug 1, 2025
Primary completion
May 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 2, 2025

Study contacts

Armin Flinspach N PD. Dr. med. habil., M.D.
Contact
armin.flinspach@unimedizin-ffm.de
+49 69 6301 84136

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion